Padmanabh Inds.

Which are the latest news on Padmanabh Inds.?

Why is Padmanabh Industries Ltd falling/rising?

As of 07-Aug, Padmanabh Industries Ltd's stock price is declining, currently at 7.68, reflecting a significant drop of -15.04% year-to-date and underperformance compared to the Sensex. The stock is trading below its moving averages, indicating a bearish trend, and investor interest has decreased markedly.

As of 07-Aug, Padmanabh Industries Ltd's stock price is falling, currently at 7.68, which reflects a change of -0.81 or -9.54%. This decline is evident in the stock's performance over various periods, showing a significant drop of -11.32% over the past week and -9.65% over the past month, while the benchmark Sensex has shown positive returns during these periods. Year-to-date, the stock has decreased by -15.04%, compared to a -7.89% decline in the Sensex, indicating underperformance relative to the market.<BR><BR>Additionally, the stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend. Investor participation has also decreased, with delivery volume on August 6 falling by -72.19% compared to the 5-day average, suggesting reduced interest from investors. Overall, these factors contribute to the downward movement of Padmanabh Industries Ltd's stock price.

Should I buy, sell or hold Padmanabh Industries Ltd?

When is the next results date for Padmanabh Industries Ltd?

The next results date for Padmanabh Industries Ltd is 22 July 2026.

The next results date for Padmanabh Industries Ltd is scheduled for 22 July 2026.

How big is Padmanabh Inds.?

As of 10th June, Padmanabh Industries Ltd has a market capitalization of 5.00 Cr, with recent net sales of 0.13 Cr and a net loss of 1.64 Cr. Shareholder's funds are 0.54 Cr, and total assets amount to 3.05 Cr.

As of 10th June, Padmanabh Industries Ltd has a market capitalization of 5.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, the company reported Net Sales of 0.13 Cr. However, it experienced a loss of 1.64 Cr in Net Profit during the same period.<BR><BR>The latest annual reporting period shows Shareholder's Funds of 0.54 Cr and Total Assets amounting to 3.05 Cr.

Who are in the management team of Padmanabh Inds.?

The management team of Padmanabh Industries includes Pranav Manoj Vajani (Independent Director), Chiragkumar Rameshbhai Parmar (Managing Director & CFO), Shvetalben S. Dataniya (Chairman & Independent Director), Viren Rajeshkumar Makwana (Additional Director), and Jayesh L Bhavsar (Company Secretary & Compliance Officer).

The management team of Padmanabh Industries includes the following individuals:<BR><BR>1. **Pranav Manoj Vajani** - Independent Director<BR>2. **Chiragkumar Rameshbhai Parmar** - Managing Director & CFO<BR>3. **Shvetalben S. Dataniya** - Chairman & Independent Director<BR>4. **Viren Rajeshkumar Makwana** - Additional Director<BR>5. **Jayesh L Bhavsar** - Company Secretary & Compliance Officer<BR><BR>If you need more information about their roles or the company, feel free to ask!

Who are the peers of the Padmanabh Inds.?

Peers of Padmanabh Inds. include Square Four Pro., Kobo Biotech, Sreechem Resins, Emmessar Biotech, Link Pharma Chem, Kuwer Industries, Lime Chemicals, and Bhagawati Oxygen. Padmanabh Inds. has an average growth rating and a 1-year return of -3.88%, while Kobo Biotech leads with a 1-year return of 134.11%.

Peers: The peers of Padmanabh Inds. are Square Four Pro., Kobo Biotech, Sreechem Resins, Emmessar Biotech, Link Pharma Chem, Kuwer Industries, Lime Chemicals, Bhagawati Oxygen.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sreechem Resins, while Average management risk is found at Emmessar Biotech and the rest. Below Average management risk is noted for Link Pharma Chem, Kuwer Industries, and Lime Chemicals. Growth is Average for Padmanabh Inds., Below Average for Sreechem Resins, Emmessar Biotech, Link Pharma Chem, Kuwer Industries, and Lime Chemicals, while Kobo Biotech does not qualify. Capital Structure ratings show Below Average for Padmanabh Inds., Sreechem Resins, Emmessar Biotech, Link Pharma Chem, Kuwer Industries, and Lime Chemicals, with Square Four Pro., Kobo Biotech, and Bhagawati Oxygen not qualifying.<BR><BR>Return Snapshot: Kobo Biotech has the highest 1-year return at 134.11%, while Bhagawati Oxygen has the lowest at -37.07%. Padmanabh Inds. has a 1-year return of -3.88%, which is higher than Bhagawati Oxygen but lower than Kobo Biotech. Additionally, Emmessar Biotech, Link Pharma Chem, Lime Chemicals, and Bhagawati Oxygen all have negative six-month returns.

What does Padmanabh Inds. do?

Padmanabh Industries Ltd trades in agricultural goods and commodity materials, classified as a micro-cap company. It reported net sales of 15 Cr and a net profit of 0 Cr for the quarter ending March 2026.

Overview:<BR>Padmanabh Industries Ltd is engaged in the trading of agriculture goods and commodity & agri materials, operating within the commodity chemicals industry and classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated as Nilchem Industries Limited on October 24, 1994, and changed its name to Padmanabh Industries Limited on December 24, 2014. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 15 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 5 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00 <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.08 <BR>Return on Equity: 50.00% <BR>Price to Book: 5.04 <BR><BR>Contact Details:<BR>Address: 401 Abhishree Avenue, Nehru Nagar Circle Ambawadi Ahmedabad Gujarat : 380015 <BR>Tel: 91-79-26400200 <BR>Email: nilchem.industries@gmail.com <BR>Website: http://www.padmanabhindustries.com

Are Padmanabh Industries Ltd latest results good or bad?

Padmanabh Industries Ltd's latest results show impressive year-on-year growth in net sales and profit, with increases of 2,471.43% and 2,100.00%, respectively. However, these gains come after a history of operational challenges and losses, so caution is advised when interpreting the results.

The latest results for Padmanabh Industries Ltd indicate a mixed picture. On one hand, there has been a significant year-on-year growth in net sales, with a remarkable increase of 2,471.43% in the quarter ended December 2025 compared to the same quarter in the previous year. Additionally, the standalone net profit also saw a substantial growth of 2,100.00% during the same period.<BR><BR>However, despite these impressive percentage increases, it's essential to consider the context. The company has faced severe operational challenges in recent years, with a history of revenue collapse and persistent losses. Prior to this recent quarter, the company reported virtually no revenue, and its financial health has been characterized by negative metrics, including a negative return on capital employed and minimal promoter holding.<BR><BR>While the latest results show positive growth, they come after a long period of distress, and the company still faces significant risks, including governance concerns and a lack of institutional investor confidence. Therefore, while the latest figures may seem good in isolation, they should be viewed cautiously in light of the company's overall financial history and current operational challenges.

How has been the historical performance of Padmanabh Inds.?

Padmanabh Inds. has experienced significant financial decline, with net sales dropping from 6.29 Cr in Mar'18 to 0.14 Cr in Mar'22, and increasing losses reflected in negative operating profit and net profit after tax. Total assets also decreased from 10.36 Cr in Mar'19 to 3.05 Cr in Mar'22, indicating overall deteriorating performance.

Answer:<BR>The historical performance of Padmanabh Inds. shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Padmanabh Inds. experienced a notable decline in net sales, dropping from 6.29 Cr in Mar'18 to just 0.14 Cr in Mar'22, with a peak of 1.61 Cr in Mar'20. The total operating income followed a similar trend, peaking at 6.29 Cr in Mar'18 and falling to 0.14 Cr in Mar'22. The company faced increasing total expenditure, which reached 0.90 Cr in Mar'22, up from 0.32 Cr in Mar'21. Operating profit (PBDIT) was negative in Mar'22 at -0.69 Cr, a decline from -0.22 Cr in Mar'21, and the profit before tax also worsened to -1.56 Cr in Mar'22 from -0.25 Cr in Mar'21. The net profit after tax reflected a similar downward trend, with losses increasing from -0.25 Cr in Mar'21 to -1.56 Cr in Mar'22. The company's total assets decreased from 10.36 Cr in Mar'19 to 3.05 Cr in Mar'22, while total liabilities also fell from 10.36 Cr in Mar'19 to 3.05 Cr in Mar'22. Cash flow from operating activities remained negative at -1.00 Cr in Mar'22, consistent with the previous year. Overall, Padmanabh Inds. has shown a deteriorating financial performance over the years, marked by declining sales, increasing losses, and reduced asset values.

Who are the top shareholders of the Padmanabh Inds.?

The top shareholders of Padmanabh Industries include promoter Jigisha Bhavinbhai Shah with 0.82% and public shareholder Ashish Mahendra Shah with 9.79%. Individual investors hold a significant 84.03% of the shares, with no institutional holdings reported.

The top shareholders of Padmanabh Industries include Jigisha Bhavinbhai Shah, who is the promoter with the highest holding at 0.82%. The highest public shareholder is Ashish Mahendra Shah, holding 9.79%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 84.03% of the shares. There are no institutional holdings from mutual funds or foreign institutional investors.

Is Padmanabh Inds. overvalued or undervalued?

As of April 25, 2023, Padmanabh Industries is considered risky but undervalued, with a PE ratio of 5.59, significantly lower than peers like MMTC and Elitecon International, suggesting potential growth despite recent underperformance compared to the Sensex.

As of 25 April 2023, the valuation grade for Padmanabh Industries has moved from does not qualify to risky. The company is currently considered undervalued. Key ratios include a PE ratio of 5.59, an EV to EBIT of 6.15, and a PEG ratio of 0.05, indicating potential for growth despite the risks involved.<BR><BR>In comparison with peers, Padmanabh Industries' PE ratio is significantly lower than that of MMTC, which stands at 119.39, and Elitecon International, which is at 131.08. This suggests that Padmanabh may be undervalued relative to its peers in the commodity chemicals industry. Additionally, while the company's recent stock performance has lagged behind the Sensex in the year-to-date period, it has outperformed the index over the past year, reinforcing the notion of potential upside if market conditions improve.

What is the technical trend for Padmanabh Inds.?

As of May 20, 2025, Padmanabh Inds. has a bullish technical trend supported by positive MACD and KST indicators, though the RSI shows no signal and Dow Theory indicates a mildly bullish trend on the weekly chart.

As of 20 May 2025, the technical trend for Padmanabh Inds. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. Daily moving averages also indicate a bullish stance. The KST is bullish on both weekly and monthly time frames, reinforcing the overall bullish sentiment. However, the RSI shows no signal on both weekly and monthly charts, and the Bollinger Bands are mildly bullish. Dow Theory indicates a mildly bullish trend on the weekly chart but shows no trend on the monthly chart. Overall, the current technical stance is bullish with moderate strength.

Has Padmanabh Inds. declared dividend?

No Dividend History Available